SEC Tracker
Get the app
ONMD · XBRL financial data

OneMedNet financial statements, every quarter

The same tables from 14 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ONMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue—year only24822714226*137155177year only96292
Revenue from contracts with customers326340*24822714226*137155177year only96292
Cost of revenue293338*31732922652*361396399726*476857
Gross profit332*(69)(102)(84)(26)*(224)(241)(222)—(380)(565)
Research and development405932*445383298340*348382323443*311324
General and administrative1,3121,376*1,3581,7161,8652,093*1,3621,1831,3862,378*1,483981
Total operating expenses1,9602,444*2,0322,3522,3032,640*2,0001,8222,0133,247*2,1721,696
Operating income (loss)(918)(5,295)*(2,101)(2,454)(2,387)(2,666)*(2,224)(2,063)(2,235)(3,082)*(2,552)(2,261)
Interest expense—(492)*25151427*312268*109
Other income (expense)(7)8*7(20)(4)(8)*—(12)(8)(60)*—2
Income tax expense (benefit)88(192)*———year only———year only——
Net income (loss)(817)(32,872)*(2,109)(3,589)(2,058)(2,374)*(1,902)2,982(741)(3,140)*(2,453)(2,172)
Earnings per share, basic USD per share(3.23)—(0.09)(0.15)(0.07)—(0.06)0.07(0.01)(0.06)*(0.04)(0.04)
Earnings per share, diluted USD per share(3.23)—(0.09)(0.15)(0.07)—(0.06)0.07(0.01)(0.06)*(0.04)(0.04)
Weighted average shares, basic thousands of shares4,281—23,68223,94027,878—34,10436,83652,61854,323*55,31658,020
Weighted average shares, diluted thousands of shares4,281—23,68223,94027,878—34,10438,40652,61852,770*55,31658,020

Balance sheet

CSV

Fiscal quarters (ONMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents612471744071,934172144122149585233358
Accounts receivable861522537563213247254582495697664
Prepaid and other current assets87166229174151385447293115509464291
Total current assets233656569564,3043,6191,6312,2671,4462,0951,4601,313
Property and equipment, net5,000999485841081017060564751
Total assets19,3314647501,0414,3883,7271,7322,3371,5062,1511,5071,364
Accrued liabilities2,836———————————
Total current liabilities3,08013,37314,65820,04618,62819,22818,1546,1595,0054,8255,3554,726
Total liabilities11,74413,90616,45120,22818,65619,67718,2826,1775,4455,1165,5864,882
Accumulated deficit(12,540)(91,440)(93,549)(97,138)(99,196)(101,569)(103,471)(100,489)(101,230)(104,370)(106,823)(108,995)
Total stockholders' equity(11,622)(13,442)(15,701)(19,187)(14,268)(15,950)(16,550)(3,840)(3,939)(2,965)(4,079)(3,518)
Total liabilities and equity19,3314647501,0414,3883,7271,7322,3371,5062,151—1,364
Common shares outstanding (cover page) thousands of shares32,26323,85027,98727,98727,98730,76130,57346,09651,00552,19754,43359,286

Cash flows

CSV

Fiscal quarters (ONMD's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(817)(32,872)*(2,109)(3,589)(2,058)(2,374)*(1,902)2,982(741)(3,140)*(2,453)(2,172)
Stock-based compensation241*586*137103*207*181*208197*142*1,485*431463*
Depreciation and amortization7*8*1110*10*26*1234*10*9*11—
Net cash from operating activities(152)*year only(1,547)(1,506)*(1,903)*(2,027)*(1,948)(2,284)*(1,558)*(1,713)*(1,542)(1,875)*
Purchases of property and equipment22*15*61*9*35*53*0*5*29*
Net cash from investing activities11,102*(10,868)*(6)(1)*(2,340)*365*1,920(670)*1,108*(51)*35256*
Proceeds from issuing common stock————————500*———
Repayments of long-term debt————100*0*——————
Net cash from financing activities(10,953)*14,666*1,6802,040*5,470*(100)*(94)3,026*477*2,200*8381,944*
Net change in cash(2)*(195)*127533*1,227*(1,762)*(28)(22)*27*436*(352)125*

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
OneMedNet358292(1,875)*59.3M0.2 quarters 10-QJun 30, 2026
IB Acquisition30not reported(474)*5.0M0.1 quarters 10-QJun 30, 2026
bioAffinity Technologies2,4301,511(3,201)*8.1M0.8 quarters 10-QJun 30, 2026
20/20 Biolabs4,546731(605)*12.8M7.5 quarters 10-QJun 30, 2026
Hypha Labs5.1not reported(52)*163.9M0.1 quarters 10-QJun 30, 2026
Cannabis Bioscience International Holdings0.111(15)*11.6B0.0 quarters 10-QFeb 28, 2026

Not investment advice. Not affiliated with the U.S. SEC.